Role of FODMAPs in Patients With Irritable Bowel Syndrome - PubMed (original) (raw)
Review
Role of FODMAPs in Patients With Irritable Bowel Syndrome
Pasquale Mansueto et al. Nutr Clin Pract. 2015 Oct.
Abstract
Irritable bowel syndrome (IBS) is a condition characterized by abdominal pain, bloating, flatus, and altered bowel habits. The role of dietary components in inducing IBS symptoms is difficult to explore. To date, foods are not considered a cause but rather symptom-triggering factors. Particular interest has been given to the so-called FODMAPs (fermentable oligo-, di-, and monosaccharides and polyols). We aimed to summarize the evidence from the most common approaches to manage suspected food intolerance in IBS, with a particular interest in the role of FODMAPs and the effects of a low FODMAP diet. We reviewed literature, consulting PubMed and Medline by using the search terms FODMAP(s), fructose, lactose, fructans, galactans, polyols (sorbitol, mannitol, maltitol, xylitol, erythritol, polydextrose, and isomalt), irritable bowel syndrome, and functional gastrointestinal symptoms. FODMAP-restricted diets have been used for a long time to manage patients with IBS. The innovation in the so-called FODMAP concept is that a global restriction should have a more consistent effect than a limited one in preventing abdominal distension. Even though all the potential low FODMAP diets provide good relief of symptoms in many patients, there is just a little relief in others. Several studies highlight the role of low FODMAP diets to improve symptoms in patients with IBS. The evidence on this dietary approach supports the hypothesis that a low FODMAP diet should be the first dietary approach. However, many points remain to be clarified, including the evaluation of possibly significant nutrition concerns.
Keywords: FODMAP; diet therapy; disaccharides, monosaccharides; gastrointestinal diseases; irritable bowel syndrome; oligosaccharides.
© 2015 American Society for Parenteral and Enteral Nutrition.
Similar articles
- A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. Halmos EP, et al. Gastroenterology. 2014 Jan;146(1):67-75.e5. doi: 10.1053/j.gastro.2013.09.046. Epub 2013 Sep 25. Gastroenterology. 2014. PMID: 24076059 Clinical Trial. - Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies.
Varjú P, Farkas N, Hegyi P, Garami A, Szabó I, Illés A, Solymár M, Vincze Á, Balaskó M, Pár G, Bajor J, Szűcs Á, Huszár O, Pécsi D, Czimmer J. Varjú P, et al. PLoS One. 2017 Aug 14;12(8):e0182942. doi: 10.1371/journal.pone.0182942. eCollection 2017. PLoS One. 2017. PMID: 28806407 Free PMC article. - [Low Fermentable Oligo-, Di- and Monosaccharides and Polyols (FODMAP) diet in the treatment of patients with irritable bowel syndrome: basic principles and methodology].
Kuvaev RO, Yakovenko EP, Nikonov EL, Zaytsev SV, Pospelova EE, Krashenkova AV. Kuvaev RO, et al. Vopr Pitan. 2020;89(6):38-47. doi: 10.24411/0042-8833-2020-10077. Epub 2020 Nov 20. Vopr Pitan. 2020. PMID: 33476497 Review. Russian. - Restriction of FODMAP in the management of bloating in irritable bowel syndrome.
Wong WM. Wong WM. Singapore Med J. 2016 Sep;57(9):476-84. doi: 10.11622/smedj.2016152. Singapore Med J. 2016. PMID: 27664186 Free PMC article. Review. - Dietary Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Gastrointestinal Disease.
Vakil N. Vakil N. Nutr Clin Pract. 2018 Aug;33(4):468-475. doi: 10.1002/ncp.10108. Epub 2018 Jun 5. Nutr Clin Pract. 2018. PMID: 29870082 Review.
Cited by
- Fermentable Oligo-, Di-, and Mono-Saccharides and Polyols (FODMAPs) Consumption and Irritable Bowel Syndrome in the French NutriNet-Santé Cohort.
Schneider E, Sabaté JM, Bouchoucha M, Hercberg S, Touvier M, Benamouzig R, Julia C, Buscail C. Schneider E, et al. Nutrients. 2021 Dec 17;13(12):4513. doi: 10.3390/nu13124513. Nutrients. 2021. PMID: 34960065 Free PMC article. - Autonomic dysreflexia in patients with cancer and spinal cord injury: a case series.
Qin E, Marshall GM, Ruppert L. Qin E, et al. Spinal Cord Ser Cases. 2024 Sep 4;10(1):66. doi: 10.1038/s41394-024-00678-7. Spinal Cord Ser Cases. 2024. PMID: 39231946 - Mast Cell Regulation and Irritable Bowel Syndrome: Effects of Food Components with Potential Nutraceutical Use.
Uranga JA, Martínez V, Abalo R. Uranga JA, et al. Molecules. 2020 Sep 20;25(18):4314. doi: 10.3390/molecules25184314. Molecules. 2020. PMID: 32962285 Free PMC article. Review. - Motility Disorders in Celiac Disease and Non-Celiac Gluten Sensitivity: The Impact of a Gluten-Free Diet.
Usai-Satta P, Oppia F, Lai M, Cabras F. Usai-Satta P, et al. Nutrients. 2018 Nov 7;10(11):1705. doi: 10.3390/nu10111705. Nutrients. 2018. PMID: 30405092 Free PMC article. Review. - The relationship between fermentable carbohydrates and post-prandial bowel symptoms in patients with functional bowel disorders.
MacIntosh A, Heenan PE, Wright-McNaughton M, Frampton C, Skidmore P, Wall CL, Muir J, Talley NJ, Roy NC, Gearry RB. MacIntosh A, et al. Front Nutr. 2023 Feb 2;10:1060928. doi: 10.3389/fnut.2023.1060928. eCollection 2023. Front Nutr. 2023. PMID: 36819701 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical